Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review
Top Cited Papers
- 30 September 2011
- journal article
- review article
- Published by Elsevier BV in European Urology
- Vol. 60 (3), 493-500
- https://doi.org/10.1016/j.eururo.2011.05.045
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the BladderEuropean Urology, 2010
- Estimates of cancer incidence and mortality in Europe in 2008European Journal of Cancer, 2010
- An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder CancerEuropean Urology, 2009
- Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancerBMC Cancer, 2009
- Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancerUrologic Oncology, 2009
- Provider Treatment Intensity and Outcomes for Patients With Early-Stage Bladder CancerJNCI Journal of the National Cancer Institute, 2009
- Clinical outcome of high‐grade non‐muscle‐invasive bladder cancer: A long‐term single center experienceInternational Journal of Urology, 2009
- Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon‐alphaCancer, 2007
- Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinomaEuropean Journal of Surgical Oncology, 2006